Real-World Data on Clinical Profile, Treatment Strategies, and Feto-Maternal Outcomes of Pregnancies Among Patients with Chronic Myeloid Leukemia in a Resource-Constrained Setting: A 5-Year Single-Center Retrospective Cohort Study

BackgroundManagement of pregnancy in chronic myeloid leukemia (CML) is challenging, particularly in resource-limited settings where access to molecular monitoring and pregnancy-compatible therapies is constrained.Tyrosine kinase inhibitors (TKIs), while highly effective, are teratogenic and often require interruption, risking disease destabilization.Real-world data from low-and middle-income countries remain limited.